Mark Dershwitz to Ondansetron
This is a "connection" page, showing publications Mark Dershwitz has written about Ondansetron.
Connection Strength
0.229
-
Dershwitz M, Conant JA, Chang Y, Rosow CE, Connors PM. A randomized, double-blind, dose-response study of ondansetron in the prevention of postoperative nausea and vomiting. J Clin Anesth. 1998 Jun; 10(4):314-20.
Score: 0.152
-
McKenzie R, Sharifi-Azad S, Dershwitz M, Miguel R, Joslyn AF, Tantisira B, Rosenblum F, Rosow CE, Downs JB, Bowie JR, et al. A randomized, double-blind pilot study examining the use of intravenous ondansetron in the prevention of postoperative nausea and vomiting in female inpatients. J Clin Anesth. 1993 Jan-Feb; 5(1):30-6.
Score: 0.026
-
Dershwitz M, Di Biase PM, Rosow CE, Wilson RS, Sanderson PE, Joslyn AF. Ondansetron does not affect alfentanil-induced ventilatory depression or sedation. Anesthesiology. 1992 Sep; 77(3):447-52.
Score: 0.026
-
Dershwitz M, Rosow CE, Di Biase PM, Joslyn AF, Sanderson PE. Ondansetron is effective in decreasing postoperative nausea and vomiting. Clin Pharmacol Ther. 1992 Jul; 52(1):96-101.
Score: 0.025